USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: GENETRONICS, INC.
Address: GENETRONICS, INC.
11199-A SORRENTO VALLEY RD
SAN DIEGO, CA 92121
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (858) 410-3117

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $755,048.00 9
SBIR Phase II $1,298,103.00 3

Award List:

CELL SEPARATION IN OSCILLATING ELECTROMAGNETIC FIELDS

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: NSF
Principal Investigator:
Award Amount: $50,000.00

THE SEPARATION OF LARGE DNA FRAGMENTS WITH OSCILLATING MAG- NETIC FIELDS

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: DOE
Principal Investigator: Dr Gunter A Hofmann
Award Amount: $50,000.00

CELL SEPARATION IN OSCILLATING ELECTROMAGNETIC FIELDS

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: NSF
Principal Investigator:
Award Amount: $225,000.00
Abstract:
A novel cell separation method utilizing oscillating electromagnetic fields is investigated. the principle of separation lies in the polarizable nature of the live cells in the electric field. in this method, a suspension of heterogenous cell mixture is subjected to oscillating electric and magnetic… More

THE SEPARATION OF LARGE DNA FRAGMENTS WITH OSCILLATING MAG- NETIC FIELDS

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: DOE
Principal Investigator: Dr Gunter A Hofmann
Award Amount: $500,000.00
Abstract:
A new method of separating large dna fragments involving oscillating electric and magnetic fields is being studied. the goal of this project is to demonstrate the feasibility of separating dna fragments (>500 kb), which is expected to substantially improve the process of sequencing the human genome.… More

Noninvasive Assessment of Embryo Viability In Vitro

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gunter Hofmann
Award Amount: $78,750.00
Abstract:
Embryo transfer (ET) procedures have gained widespread usage in modern human and animalprograms of assisted reproduction. However, to optimize ET success rates, an objective test is neededto accurately determine the viability of individual preimplantation embryos: l) following embryo collection,2)… More

Novel and Efficient Method of Anticancer Drug Delivery

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: Sukhendu Dev
Award Amount: $83,760.00
Abstract:
The contents of this proposal are based on the observation that, both in vitro and in vivo, the cytanticancer drugs can be greatly increased if cells are transiently permeabilized, allowing easier paapplication of short and intense pulsed electric fields. The objectives and specific aims of this… More

IN VIVO ARTERIAL GENE DELIVERY BY ELECTROPORATION

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $95,468.00

SUSTAINED DELIVERY OF HEPARIN INTO ARTERIAL WALL

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Dev, sukhendu b
Award Amount: $99,909.00

Novel and Efficient method of Anticancer Drug Delivery

Award Year / Program / Phase: 1997 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $573,103.00

ELECTRICALLY ENHANCED TRANSDERMAL DELIVERY OF CALCITONIN

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hofmann, Gunter A
Award Amount: $94,301.00

IN VIVO SKIN TARGETED GENE THERAPY BY ELECTROPORATION

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lei Zhang
Award Amount: $99,995.00
Abstract:
Not Available Developing a new capability to monitor accumulation of fatigue damage prior to crack initiation in critical aircraft structures is proposed. New permanently mountable eddy current sensor arrays, called MWM-Arrays, have been developed by JENTEK and have been demonstrated on… More

Ex vivo venous gene delivery by pulsed electric-fields

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nagendu B. Dev
Award Amount: $102,865.00
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this project is to make gene therapy based prevention of coronary and peripheral vascular graft-induced occlusion and restenosis feasible by developing a safe, effective and economical DNA delivery method based on electroporation.… More